Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study peiris2003clinical

This study measured SARS detected by real-time reverse transcriptase PCR in nasopharyngeal samples from 14 patients who admitted to the United Christian Hospital from the Amoy Gardens housing estate who fulfilled the modified WHO definition of SARS, on days 5, 10, and 15 after symptom onset.

Analytes

NPS_SARS

This analyte indicates the detection of SARS RNA in nasopharyngeal aspirates.

exponential for NPS_SARS

Fitted by censored maximum likelihood. The red line is the median individual; the shaded region is the full range of a simulated cohort drawn from the fitted population, so it shows what simulating from this dataset would produce rather than a confidence interval, with dashed lines at the central 95%. Open triangles are non-detects, drawn at the censoring limit and entering the fit as "below this value" rather than being dropped. See the modelling methods for what these estimates do and do not support.

Biomarker: SARS
Specimen: nasopharyngeal swab
Units: gc/mL
Gene target: unkonw
Participants: 14
Negative samples: 0
Positive samples (not quantifiable): 0
Quantifiable samples: 42
Limit of quantification: unknown
Limit of detection: unknown